Researchers Say FDA Increases Public Risks By Delaying Safety Data Release
March 09, 2007 | Instead, the FDA shrouds clinical trial data in secrecy, releasing it only when forced to do so. Such legal wrangling is a time-consuming process that comes at the expense of public health, said the lead author of a commentary published this morning in the March/April issue of the journal Health Affairs. Story in The Boston Globe.
Feeds